Patents
Patents for A61K 47 - Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives (171,128)
03/2004
03/04/2004US20040043922 Treatment of case-ready food products with immobilized lactoferrin (Im-LF) and the products so produced
03/04/2004US20040043463 Comprises inhibitory fusion protein topical for treating aberration affecting hair pigmentation, skin pigmentation and/or skin conditioning
03/04/2004US20040043417 Generation and screening of a dynamic combinatorial library
03/04/2004US20040043076 Containing protein active material; solvent-free
03/04/2004US20040043074 Oxidized collagen formulations for use with non-compatible pharmaceutical agents
03/04/2004US20040043072 Alleviation of upper gastrointestinal irritation
03/04/2004US20040043067 Fluorosiloxane matrix controlled diffusion drug delivery systems
03/04/2004US20040043043 Gelling, thickening solutions of water soluble vitamins with triglycerides and emulsifiers
03/04/2004US20040043038 Vaccines
03/04/2004US20040043030 Polymeric delivery systems
03/04/2004US20040043029 Novel antibodies reactive with human carcinomas
03/04/2004US20040043007 Transfection system
03/04/2004US20040043002 Polyol-IFN-beta conjugate and composition containing same
03/04/2004US20040043001 Pharmaceutical formulations of antineoplastic agents and processes of making and using the same
03/04/2004US20040042990 Composition containing oxidation-sensitive hydrophilic active principle and maleic anhydride copolymer, and use thereof
03/04/2004US20040042973 Anhydrous mometasome furoate mixture with surfactant and propellant; pressurized vessel; controlling particle size distribution
03/04/2004US20040042961 Using mutant green fluorescent protein
03/04/2004US20040040227 Material for improving living environment, and building material, laying material and spraying agent using the same
03/04/2004DE10261126A1 Lagerungsstabile, flüssige Fibrinogen-Formulierung Storage stable liquid fibrinogen formulation
03/04/2004DE10239999A1 Granulat oder Pulver zur Herstellung von Überzugs- und Bindemitteln für Arzneiformen Granules or powders for the preparation of coatings and binders for pharmaceutical forms
03/04/2004CA2733212A1 Arginine silicate inositol complex and use thereof
03/04/2004CA2496952A1 Composite peptide compounds for diagnosis and treatment of diseases caused by prion proteins
03/04/2004CA2496422A1 Therapeutic uses of monoclonal antibodies to the angiotensin-ii type-1 receptor
03/04/2004CA2496376A1 Methods of drug delivery using sulphated chitinous polymers
03/04/2004CA2495923A1 Methods for treating fungal infections
03/04/2004CA2495913A1 Non-vesicular cationic lipid formulations
03/04/2004CA2495689A1 Pharmaceutical compositions
03/04/2004CA2494974A1 Il-7 drug substance, composition, preparation and uses
03/04/2004CA2491758A1 Blood clot-targeted nanoparticles
03/03/2004EP1394180A1 Synthetic mimetic molecules of physiological binding molecules
03/03/2004EP1393750A2 Conjugates for treating an immune disease
03/03/2004EP1393749A1 A pharmaceutical preparation in colloidal form useful in the treatment of skin diseases, comprising hyluronic acid
03/03/2004EP1393741A1 Storage-stable, liquid fibrinogen-formulation
03/03/2004EP1393732A1 Minoxidil-containing liquid composition
03/03/2004EP1393723A2 Use of nitric oxide-adducts to prevent thrombosis on artificial and vascular surfaces
03/03/2004EP1393721A1 Dosage form of powder agglomerates
03/03/2004EP1393719A1 Camptothecin-carboxylate formulations
03/03/2004EP1393713A1 Liquid concentrate for the preservation of cosmetic and pharmaceutical products
03/03/2004EP1392846A2 METHODS AND COMPOSITIONS FOR MODIFYING APOLIPOPROTEIN B mRNA EDITING
03/03/2004EP1392756A2 Lipid-polymer-conjugates
03/03/2004EP1392755A1 Lipid-polymer-conjugates compositions
03/03/2004EP1392751A1 Biodegradable copolymers linked to segment with a plurality of functional groups
03/03/2004EP1392714A1 Steroids as agonists for fxr
03/03/2004EP1392666A1 Biologically active methylene blue derivatives
03/03/2004EP1392485A1 Method for injection moulding moulded bodies consisting of (meth)acrylate copolymers
03/03/2004EP1392389A2 Microprojection array having a beneficial agent containing coating
03/03/2004EP1392375A2 Composition and use of substances for stabilising amino acids containing sulphur
03/03/2004EP1392366A1 Nuclear receptor-mediated introduction of a pna into cell nuclei
03/03/2004EP1392365A2 Compositions and therapeutical use of polynucleotides encoding tcrs
03/03/2004EP1392364A2 Liquid polymer composition for prevention and treatment of the oral cavity diseases
03/03/2004EP1392360A2 Modified antibodies to prostate-specific membrane antigen and uses thereof
03/03/2004EP1392337A1 Pharmaceutical formulation consisting of a plant dry extract with a calcium coating
03/03/2004EP1392327A2 Use of azithromycin for the manufacture of a medicament for treatment of non-infective inflammatory diseases
03/03/2004EP1392325A1 Method of administration of bisphosphonates by inhalation in the treatment or prevention of bone resorption and osteoporosis
03/03/2004EP1392321A1 Method of treating inflammatory disorders of the gastrointestinal tract using topical active corticosteroids
03/03/2004EP1392297A1 Pharmaceutical composition comprising a tricyclic compound for the prevention or treatment of skin diseases
03/03/2004EP1392293A1 Method for treatment of tumors using nordihydroguaiaretic acid derivatives
03/03/2004EP1392279A1 Trimethyl lock based tetrapartate prodrugs
03/03/2004EP1392272A1 Permeation enhancers
03/03/2004EP1392264A1 Delivery of antiemetics through an inhalation route
03/03/2004EP1392262A1 Delivery of drug esters through an inhalation route
03/03/2004EP1392261A2 Delivery of nonsteroidal antiinflammatory drugs through an inhalation route
03/03/2004EP1392259A2 Delivery of erectile dysfunction drugs through an inhalation route
03/03/2004EP1392258A2 Delivery of alprazolam, estazolam, midazolam or triazolam throughan inhalation route
03/03/2004EP1392257A1 Delivery of antihistamines through an inhalation route
03/03/2004EP1392256A1 Improved transdermal therapeutic system for the treatment of parkinson's disese
03/03/2004EP1392255A1 Nanoparticles made of protein with coupled apolipoprotein e for penetration of the blood-brain barrier and methods for the production thereof
03/03/2004EP1392254A1 Micellar drug delivery systems for hydrophobic drugs
03/03/2004EP1392253A2 Gelatin substitute
03/03/2004EP1392250A2 Controlled release dosage forms using acrylic polymer, and process for making the same
03/03/2004EP1392249A1 Nsaid formulation comprising a granular composition and an extra-granular composition
03/03/2004EP1392246A1 Compaction process for manufacture of sodium phenytoin dosage form
03/03/2004EP1392244A2 Pharmaceutical compositions
03/03/2004EP1392241A2 System for osmotic delivery of pharmaceutically active agents
03/03/2004EP1392204A2 Bifunctional energy-reversible acyl-compositions
03/03/2004EP1392116A1 Solutions of alkoxylated alkanol amide surfactants and antimicrobial compounds
03/03/2004EP1392115A1 Controlled release particles
03/03/2004EP1259128A4 Water containing soluble fiber
03/03/2004EP1169064B1 Method of detecting endometriosis
03/03/2004EP1162953B1 Mechanically stable pharmaceutical presentation form containing liquid or semi-solid surface-active substances
03/03/2004EP1140020B1 Large molecule drug delivery system using aerosolized membrane-mimetic amphiphiles
03/03/2004EP1140012B1 Conversion of liquid filled gelatin capsules into controlled release systems by multiple coatings
03/03/2004EP1113787B1 Multiple unit controlled food effect-independent release pharmaceutical preparations and method for preparing the same
03/03/2004EP1037615B1 Compositions and methods for treatment of attention deficit disorder and attention deficit/hyperactivity disorder with methylphenidate
03/03/2004EP1019025B1 Peptide/lipid complex formation by co-lyophilization
03/03/2004EP0938341B1 Compositions and methods for altering the biodistribution of biological agents
03/03/2004EP0893992B1 Fast disintegrating oral dosage form
03/03/2004EP0874558B8 Liquid oral compositions comprising a calcium compound and an acidulant
03/03/2004EP0859628B9 Drug, in particular for modulating the immunological response for the control of viruses, tumours, bacteria and parasites
03/03/2004EP0831850B1 Use of locally applied dna fragments
03/03/2004EP0749304B2 Slow-release tablet containing diclofenac-na
03/03/2004EP0636028B1 Self-assembling polynucleotide delivery system comprising an amphiphatic cationic peptide
03/03/2004CN1479632A Complexes for transferring necleic acids into cells
03/03/2004CN1479631A Reversible gelling system for ocular drug delivery
03/03/2004CN1479625A Herbal pharmaceutical compositions for treating immun logical disorders
03/03/2004CN1479623A Antimonocytic activity of extracts of piper betel leaves
03/03/2004CN1479620A Oral extended release formulation of gepirone
03/03/2004CN1479617A N-methyl-D-aspartate receptor agonist pharmaceutical compositions
03/03/2004CN1479613A Rapidly disintegrating tablet comprising acid-sensitive active ingredient
03/03/2004CN1479612A Pharmaceutical compositions for oral delivery of pharmacologically active agents